Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Anavex Secures cGMP Manufacture for ANAVEX Trials | Contract Pharma

What are you searching for?

Sign in
Breaking News

Anavex Secures cGMP Manufacture for ANAVEX Trials

Phase IIa trial scheduled for 2014

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Anavex Life Sciences Corp. has secured cGMP manufacture of ANAVEX 2-73 for its clinical trial supplies. Further details were not disclosed.
 
“We are delighted to have the active drug product (API) manufactured and available for our Phase IIa trial,” said Christopher U. Missling, PhD, president and chief executive officer of Anavex. “We look forward to initiating clinical trials with ANAVEX PLUS for the treatment of Alzheimer’s disease, which remains on track to commence in 2014 with data from the first part of the trial expected to be reported in mid 2015.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics